These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16417033)

  • 1. Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data.
    Seed J; Carney EW; Corley RA; Crofton KM; DeSesso JM; Foster PM; Kavlock R; Kimmel G; Klaunig J; Meek ME; Preston RJ; Slikker W; Tabacova S; Williams GM; Wiltse J; Zoeller RT; Fenner-Crisp P; Patton DE
    Crit Rev Toxicol; 2005; 35(8-9):664-72. PubMed ID: 16417033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework for human relevance analysis of information on carcinogenic modes of action.
    Meek ME; Bucher JR; Cohen SM; Dellarco V; Hill RN; Lehman-McKeeman LD; Longfellow DG; Pastoor T; Seed J; Patton DE
    Crit Rev Toxicol; 2003; 33(6):591-653. PubMed ID: 14727733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action in relevance of rodent liver tumors to human cancer risk.
    Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
    Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human relevance of information on carcinogenic modes of action: overview.
    Cohen SM; Meek ME; Klaunig JE; Patton DE; Fenner-Crisp PA
    Crit Rev Toxicol; 2003; 33(6):581-9. PubMed ID: 14727732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop.
    Andersen ME; Preston RJ; Maier A; Willis AM; Patterson J
    Crit Rev Toxicol; 2014 Jan; 44(1):50-63. PubMed ID: 24083384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
    Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
    Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action human relevance (species concordance) framework: Evolution of the Bradford Hill considerations and comparative analysis of weight of evidence.
    Meek ME; Palermo CM; Bachman AN; North CM; Jeffrey Lewis R
    J Appl Toxicol; 2014 Jun; 34(6):595-606. PubMed ID: 24777878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human relevance framework evaluation of a novel rat developmental toxicity mode of action induced by sulfoxaflor.
    Ellis-Hutchings RG; Rasoulpour RJ; Terry C; Carney EW; Billington R
    Crit Rev Toxicol; 2014 May; 44 Suppl 2():45-62. PubMed ID: 24832553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPCS framework for analyzing the relevance of a noncancer mode of action for humans.
    Boobis AR; Doe JE; Heinrich-Hirsch B; Meek ME; Munn S; Ruchirawat M; Schlatter J; Seed J; Vickers C
    Crit Rev Toxicol; 2008; 38(2):87-96. PubMed ID: 18259981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using mode of action information to improve regulatory decision-making: an ECETOC/ILSI RF/HESI workshop overview.
    Carmichael N; Bausen M; Boobis AR; Cohen SM; Embry M; Fruijtier-Pölloth C; Greim H; Lewis R; Bette Meek ME; Mellor H; Vickers C; Doe J
    Crit Rev Toxicol; 2011 Mar; 41(3):175-86. PubMed ID: 21401325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human relevance framework for rodent liver tumors induced by the insecticide sulfoxaflor.
    LeBaron MJ; Gollapudi BB; Terry C; Billington R; Rasoulpour RJ
    Crit Rev Toxicol; 2014 May; 44 Suppl 2():15-24. PubMed ID: 24832551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action frameworks: a critical analysis.
    Guyton KZ; Barone S; Brown RC; Euling SY; Jinot J; Makris S
    J Toxicol Environ Health B Crit Rev; 2008 Jan; 11(1):16-31. PubMed ID: 18176885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedural application of mode-of-action and human relevance analysis: styrene-induced lung tumors in mice.
    Frank EA; Meek MEB
    Crit Rev Toxicol; 2024 Feb; 54(2):134-151. PubMed ID: 38440945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Integration of Mode of Action Information in Dose-Response Modeling and POD Estimation for Nonmutagenic Carcinogens: A Case Study of TCDD.
    Chen Q; Zhou Y; Ji C; Klaunig JE; Shao K
    Environ Health Perspect; 2023 Dec; 131(12):127022. PubMed ID: 38157272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevance.
    Criswell KA; Cook JC; Wojcinski Z; Pegg D; Herman J; Wesche D; Giddings J; Brady JT; Anderson T
    Toxicol Sci; 2012 Jul; 128(1):57-71. PubMed ID: 22539620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the human carcinogenic potential of tetrahydrofuran: I. Mode of action and human relevance analysis of the male rat kidney tumor.
    Fenner-Crisp PA; Mayes ME; David RM
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):20-39. PubMed ID: 21316415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mode of action-based probabilistic framework of dose-response assessment for nonmutagenic liver carcinogens: a case study of PCB-126.
    Zhou Y; Chen Q; Klaunig JE; Shao K
    Toxicol Sci; 2023 Nov; 196(2):250-260. PubMed ID: 37643630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action assessment for propylene dichloride as a human carcinogen.
    Kozal JS; Lynch HN; Klapacz J; Schoeny RS; Jean PA; Maier A
    Chem Biol Interact; 2023 Sep; 382():110382. PubMed ID: 36754223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.